Serotonin toxicity with therapeutic doses of dexamphetamine and venlafaxine

Medical Journal of Australia

Volumn 176, Issue 5, 2002, Pages 240-241

  Prior, Felicity H ^a   Isbister, Geoffrey K ^a   Dawson, Andrew H ^a   Whyte, Ian M ^a  

^a UNIVERSITY OF NEWCASTLE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CITALOPRAM; CYPROHEPTADINE; DEXAMPHETAMINE; SEROTONIN 2 ANTAGONIST; SEROTONIN UPTAKE INHIBITOR; VENLAFAXINE;

ADULT; ADULT DISEASE; AGITATION; ANXIETY; ATTENTION DEFICIT DISORDER; CARDIOVASCULAR PARAMETERS; CASE REPORT; DIAPHORESIS; DOSE RESPONSE; DRUG MONITORING; DRUG WITHDRAWAL; ELECTROCARDIOGRAPHY; HOSPITAL DISCHARGE; HUMAN; HYPERREFLEXIA; LETTER; MALE; MUSCLE HYPERTONIA; RETREATMENT; SEROTONIN SYNDROME; SHIVERING; SINUS TACHYCARDIA; SYMPTOM; TREMOR;

EID: 0037017741     PISSN: 0025729X     EISSN: None     Source Type: Journal    
DOI: 10.5694/j.1326-5377.2002.tb04385.x     Document Type: Letter

References (5)

1. 5-Hydroxytryptamine involvement in the locomotor activity suppressant effects of amphetamine in the mouse
2. Catecholamines, sympathomimetic drugs and adrenergic receptor antagonists
3. Venlafaxine: A structurally unique and novel antidepressant
4. Citalopram in the treatment of depression
5. Serotonin syndrome resulting from drug interactions